We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Corynebacterium jeikeium
From WikEM
(Redirected from C. jeikeium)
Contents
Background
Antibiotic Sensitivities[1]
Category | Antibiotic | C. jeikeium |
Penicillins | Penicillin G | R |
Penicillin V | R | |
Methicillin | R | |
Nafcillin/Oxacillin | R | |
Cloxacillin/Diclox. | R | |
Amino-Penicillins | AMP/Amox | R |
Amox-Clav | R | |
AMP-Sulb | R | |
Anti-Pseudomonal Penicillins | Ticarcillin | R |
Ticar-Clav | R | |
Pip-Tazo | X1 | |
Piperacillin | R | |
Carbapenems | Doripenem | X1 |
Ertapenem | R | |
Imipenem | R | |
Meropenem | X1 | |
Aztreonam | R | |
Fluroquinolones | Ciprofloxacin | R |
Ofloxacin | R | |
Pefloxacin | X1 | |
Levofloxacin | X1 | |
Moxifloxacin | X1 | |
Gemifloxacin | X1 | |
Gatifloxacin | X1 | |
1st G Cephalo | Cefazolin | R |
2nd G. Cephalo | Cefotetan | R |
Cefoxitin | R | |
Cefuroxime | R | |
3rd/4th G. Cephalo | Cefotaxime | R |
Cefizoxime | R | |
CefTRIAXone | R | |
Ceftaroline | X1 | |
CefTAZidime | R | |
Cefepime | ||
Oral 1st G. Cephalo | Cefadroxil | R |
Cephalexin | R | |
Oral 2nd G. Cephalo | Cefaclor/Loracarbef | R |
Cefproxil | R | |
Cefuroxime axetil | R | |
Oral 3rd G. Cephalo | Cefixime | R |
Ceftibuten | R | |
Cefpodox/Cefdinir/Cefditoren | X1 | |
Aminoglycosides | Gentamicin | R |
Tobramycin | R | |
Amikacin | R | |
Chloramphenicol | R | |
Clindamycin | R | |
Macrolides | Erythromycin | R |
Azithromycin | R | |
Clarithromycin | R | |
Ketolide | Telithromycin | R |
Tetracyclines | Doxycycline | R |
Minocycline | R | |
Glycylcycline | Tigecycline | S |
Daptomycin | S | |
Glyco/Lipoclycopeptides | Vancomycin | S |
Teicoplanin | S | |
Telavancin | S | |
Fusidic Acid | S | |
Trimethoprim | R | |
TMP-SMX | R | |
Urinary Agents | Nitrofurantoin | R |
Fosfomycin | X1 | |
Other | Rifampin | S |
Metronidazole | R | |
Quinupristin dalfoppristin | S | |
Linezolid | S | |
Colistimethate | R |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
|
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2010